US Stock MarketDetailed Quotes

JNJ Johnson & Johnson

Watchlist
  • 144.470
  • +0.890+0.62%
Close Dec 20 16:00 ET
  • 144.470
  • 0.0000.00%
Post 20:01 ET
347.83BMarket Cap23.49P/E (TTM)

Johnson & Johnson Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 29, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Oct 1, 2023
(Q2)Jun 30, 2023
(Q1)Apr 2, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
6.73%7.99B
34.70%5.63B
12.28%3.66B
7.54%22.79B
46.97%7.86B
19.18%7.49B
-25.07%4.18B
-18.15%3.26B
-9.47%21.19B
-6.66%5.35B
Net income from continuing operations
-89.65%2.69B
-8.90%4.69B
4,886.76%3.26B
95.94%35.15B
15.03%4.05B
483.85%26.03B
6.86%5.14B
-101.32%-68M
-14.07%17.94B
-25.68%3.52B
Operating gains losses
99.99%-2M
----
----
-5,452.89%-21.1B
--0
---21.05B
13.33%-39M
95.24%-8M
38.41%-380M
-943.75%-167M
Depreciation and amortization
0.93%1.85B
-7.86%1.78B
-3.46%1.82B
7.40%7.49B
4.01%1.84B
8.55%1.83B
10.89%1.93B
6.27%1.88B
-5.68%6.97B
-3.85%1.77B
Deferred tax
-83.93%90M
13.02%-695M
-1.23%-1.56B
-152.19%-4.19B
-392.36%-2.41B
502.88%560M
43.85%-799M
-66.63%-1.54B
20.01%-1.66B
70.10%825M
Other non cash items
----
----
----
--483M
----
----
----
----
----
----
Change In working capital
403.82%1.83B
81.17%-452M
-114.94%-338M
162.50%2.51B
362.07%3.25B
-1,906.67%-602M
-79,933.33%-2.4B
182.62%2.26B
5.36%-4.01B
20.98%-1.24B
-Change in receivables
61.90%-96M
-62.20%-884M
-416.67%-279M
51.63%-624M
-24.58%227M
-22.93%-252M
43.17%-545M
87.35%-54M
46.29%-1.29B
151.54%301M
-Change in inventory
57.65%-299M
-80.18%-391M
33.59%-348M
47.65%-1.32B
119.08%124M
-13.87%-706M
66.97%-217M
12.67%-524M
-102.48%-2.53B
-828.57%-650M
-Change in payables and accrued expense
31.25%2.26B
94.04%2.93B
3.46%-2.48B
113.66%2.35B
75.76%1.68B
31.58%1.73B
-8.26%1.51B
8.70%-2.57B
-54.94%1.1B
-57.56%957M
-Change in other current assets
-1,153.15%-2.78B
332.31%532M
449.62%3.2B
-606.55%-3.48B
45.46%-2.11B
-121.43%-222M
-109.04%-229M
-191.96%-915M
134.98%687M
4.20%-3.88B
-Change in other current liabilities
339.06%2.74B
9.59%-2.64B
-106.75%-427M
382.36%5.59B
64.02%3.33B
26.10%-1.15B
-13.83%-2.92B
5,652.73%6.33B
-86.52%-1.98B
131.36%2.03B
Cash from discontinued investing activities
Operating cash flow
6.73%7.99B
34.70%5.63B
12.28%3.66B
7.54%22.79B
46.97%7.86B
19.18%7.49B
-25.07%4.18B
-18.15%3.26B
-9.47%21.19B
-6.66%5.35B
Investing cash flow
Cash flow from continuing investing activities
-223.10%-3.13B
-262.47%-13.69B
-114.00%-464M
107.10%878M
72.66%-1.2B
249.38%2.54B
-43.08%-3.78B
191.22%3.32B
-42.47%-12.37B
17.97%-4.4B
Net PPE purchase and sale
-6.41%-1.03B
13.17%-976M
6.49%-807M
-13.32%-4.54B
-0.13%-1.59B
-1.58%-967M
-30.24%-1.12B
-42.17%-863M
-9.78%-4.01B
-12.16%-1.59B
Net intangibles purchase and sale
----
----
----
---470M
---470M
----
----
----
--0
----
Net business purchase and sale
---338M
---13B
---1.81B
--0
--0
--0
--0
--0
-29,320.00%-17.65B
-28,450.00%-17.13B
Net investment purchase and sale
-128.18%-1.24B
161.63%1.6B
-91.26%349M
-8.03%8.48B
-80.96%2.68B
1,163.86%4.42B
-52.19%-2.6B
247.03%3.99B
271.21%9.23B
519.32%14.06B
Net other investing changes
180.82%733M
-2,484.31%-1.32B
870.43%1.81B
-4,089.23%-2.59B
-811.33%-1.82B
-170.75%-907M
-125.00%-51M
410.00%186M
-84.41%65M
148.21%256M
Cash from discontinued investing activities
Investing cash flow
-223.10%-3.13B
-262.47%-13.69B
-114.00%-464M
107.10%878M
72.66%-1.2B
249.38%2.54B
-43.08%-3.78B
191.22%3.32B
-42.47%-12.37B
17.97%-4.4B
Financing cash flow
Cash flow from continuing financing activities
12.68%-9.88B
225.92%7.54B
-91.10%546M
-78.39%-15.83B
-373.82%-4.66B
-188.33%-11.32B
-164.97%-5.99B
239.98%6.14B
36.85%-8.87B
149.48%1.7B
Net issuance payments of debt
0.27%-7.4B
262.65%11.54B
-66.04%4.37B
-136.69%-2.73B
-115.03%-1.1B
-6,336.13%-7.42B
-78,955.56%-7.1B
41,448.39%12.88B
852.73%7.45B
243,200.00%7.29B
Net common stock issuance
41.41%-539M
-103.52%-136M
58.30%-1.48B
86.53%-813M
83.64%-216M
57.51%-920M
496.71%3.86B
-124.29%-3.54B
-74.62%-6.04B
-32.53%-1.32B
Cash dividends paid
-3.97%-2.99B
3.46%-2.99B
2.48%-2.87B
-0.75%-11.77B
3.01%-2.87B
3.33%-2.87B
-4.07%-3.09B
-5.56%-2.94B
-5.89%-11.68B
-5.84%-2.95B
Proceeds from stock option exercised by employees
-35.07%424M
-64.15%95M
1,872.73%195M
-17.68%1.09B
-55.69%187M
650.57%653M
-46.89%265M
-103.43%-11M
28.28%1.33B
85.09%422M
Net other financing activities
181.66%619M
-1,432.88%-973M
227.38%321M
-2,564.62%-1.6B
61.80%-665M
-175.50%-758M
-93.79%73M
32.44%-252M
-83.54%65M
-1,481.75%-1.74B
Cash from discontinued financing activities
Financing cash flow
12.68%-9.88B
225.92%7.54B
-91.10%546M
-78.39%-15.83B
-373.82%-4.66B
-188.33%-11.32B
-164.97%-5.99B
239.98%6.14B
36.85%-8.87B
149.48%1.7B
Net cash flow
Beginning cash position
17.44%24.88B
-5.18%25.47B
54.73%21.86B
-2.48%14.13B
73.74%19.73B
92.87%21.18B
156.76%26.87B
-2.48%14.13B
3.59%14.49B
-35.50%11.36B
Current changes in cash
-289.82%-5.02B
90.87%-510M
-70.58%3.74B
16,441.67%7.84B
-24.39%2.01B
-295.59%-1.29B
-920.12%-5.59B
414.60%12.71B
-107.06%-48M
186.59%2.65B
Effect of exchange rate changes
170.83%119M
12.37%-85M
-546.43%-125M
64.10%-112M
5.04%125M
41.26%-168M
39.75%-97M
75.00%28M
-75.28%-312M
324.53%119M
End cash Position
1.28%19.98B
17.44%24.88B
-5.18%25.47B
54.73%21.86B
54.73%21.86B
73.74%19.73B
92.87%21.18B
156.76%26.87B
-2.48%14.13B
-2.48%14.13B
Free cash flow
-12.39%5.71B
52.29%4.66B
19.05%2.85B
3.45%17.78B
54.24%5.8B
22.32%6.52B
-35.18%3.06B
-29.00%2.39B
-13.02%17.19B
-12.83%3.76B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 29, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Oct 1, 2023(Q2)Jun 30, 2023(Q1)Apr 2, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 6.73%7.99B34.70%5.63B12.28%3.66B7.54%22.79B46.97%7.86B19.18%7.49B-25.07%4.18B-18.15%3.26B-9.47%21.19B-6.66%5.35B
Net income from continuing operations -89.65%2.69B-8.90%4.69B4,886.76%3.26B95.94%35.15B15.03%4.05B483.85%26.03B6.86%5.14B-101.32%-68M-14.07%17.94B-25.68%3.52B
Operating gains losses 99.99%-2M---------5,452.89%-21.1B--0---21.05B13.33%-39M95.24%-8M38.41%-380M-943.75%-167M
Depreciation and amortization 0.93%1.85B-7.86%1.78B-3.46%1.82B7.40%7.49B4.01%1.84B8.55%1.83B10.89%1.93B6.27%1.88B-5.68%6.97B-3.85%1.77B
Deferred tax -83.93%90M13.02%-695M-1.23%-1.56B-152.19%-4.19B-392.36%-2.41B502.88%560M43.85%-799M-66.63%-1.54B20.01%-1.66B70.10%825M
Other non cash items --------------483M------------------------
Change In working capital 403.82%1.83B81.17%-452M-114.94%-338M162.50%2.51B362.07%3.25B-1,906.67%-602M-79,933.33%-2.4B182.62%2.26B5.36%-4.01B20.98%-1.24B
-Change in receivables 61.90%-96M-62.20%-884M-416.67%-279M51.63%-624M-24.58%227M-22.93%-252M43.17%-545M87.35%-54M46.29%-1.29B151.54%301M
-Change in inventory 57.65%-299M-80.18%-391M33.59%-348M47.65%-1.32B119.08%124M-13.87%-706M66.97%-217M12.67%-524M-102.48%-2.53B-828.57%-650M
-Change in payables and accrued expense 31.25%2.26B94.04%2.93B3.46%-2.48B113.66%2.35B75.76%1.68B31.58%1.73B-8.26%1.51B8.70%-2.57B-54.94%1.1B-57.56%957M
-Change in other current assets -1,153.15%-2.78B332.31%532M449.62%3.2B-606.55%-3.48B45.46%-2.11B-121.43%-222M-109.04%-229M-191.96%-915M134.98%687M4.20%-3.88B
-Change in other current liabilities 339.06%2.74B9.59%-2.64B-106.75%-427M382.36%5.59B64.02%3.33B26.10%-1.15B-13.83%-2.92B5,652.73%6.33B-86.52%-1.98B131.36%2.03B
Cash from discontinued investing activities
Operating cash flow 6.73%7.99B34.70%5.63B12.28%3.66B7.54%22.79B46.97%7.86B19.18%7.49B-25.07%4.18B-18.15%3.26B-9.47%21.19B-6.66%5.35B
Investing cash flow
Cash flow from continuing investing activities -223.10%-3.13B-262.47%-13.69B-114.00%-464M107.10%878M72.66%-1.2B249.38%2.54B-43.08%-3.78B191.22%3.32B-42.47%-12.37B17.97%-4.4B
Net PPE purchase and sale -6.41%-1.03B13.17%-976M6.49%-807M-13.32%-4.54B-0.13%-1.59B-1.58%-967M-30.24%-1.12B-42.17%-863M-9.78%-4.01B-12.16%-1.59B
Net intangibles purchase and sale ---------------470M---470M--------------0----
Net business purchase and sale ---338M---13B---1.81B--0--0--0--0--0-29,320.00%-17.65B-28,450.00%-17.13B
Net investment purchase and sale -128.18%-1.24B161.63%1.6B-91.26%349M-8.03%8.48B-80.96%2.68B1,163.86%4.42B-52.19%-2.6B247.03%3.99B271.21%9.23B519.32%14.06B
Net other investing changes 180.82%733M-2,484.31%-1.32B870.43%1.81B-4,089.23%-2.59B-811.33%-1.82B-170.75%-907M-125.00%-51M410.00%186M-84.41%65M148.21%256M
Cash from discontinued investing activities
Investing cash flow -223.10%-3.13B-262.47%-13.69B-114.00%-464M107.10%878M72.66%-1.2B249.38%2.54B-43.08%-3.78B191.22%3.32B-42.47%-12.37B17.97%-4.4B
Financing cash flow
Cash flow from continuing financing activities 12.68%-9.88B225.92%7.54B-91.10%546M-78.39%-15.83B-373.82%-4.66B-188.33%-11.32B-164.97%-5.99B239.98%6.14B36.85%-8.87B149.48%1.7B
Net issuance payments of debt 0.27%-7.4B262.65%11.54B-66.04%4.37B-136.69%-2.73B-115.03%-1.1B-6,336.13%-7.42B-78,955.56%-7.1B41,448.39%12.88B852.73%7.45B243,200.00%7.29B
Net common stock issuance 41.41%-539M-103.52%-136M58.30%-1.48B86.53%-813M83.64%-216M57.51%-920M496.71%3.86B-124.29%-3.54B-74.62%-6.04B-32.53%-1.32B
Cash dividends paid -3.97%-2.99B3.46%-2.99B2.48%-2.87B-0.75%-11.77B3.01%-2.87B3.33%-2.87B-4.07%-3.09B-5.56%-2.94B-5.89%-11.68B-5.84%-2.95B
Proceeds from stock option exercised by employees -35.07%424M-64.15%95M1,872.73%195M-17.68%1.09B-55.69%187M650.57%653M-46.89%265M-103.43%-11M28.28%1.33B85.09%422M
Net other financing activities 181.66%619M-1,432.88%-973M227.38%321M-2,564.62%-1.6B61.80%-665M-175.50%-758M-93.79%73M32.44%-252M-83.54%65M-1,481.75%-1.74B
Cash from discontinued financing activities
Financing cash flow 12.68%-9.88B225.92%7.54B-91.10%546M-78.39%-15.83B-373.82%-4.66B-188.33%-11.32B-164.97%-5.99B239.98%6.14B36.85%-8.87B149.48%1.7B
Net cash flow
Beginning cash position 17.44%24.88B-5.18%25.47B54.73%21.86B-2.48%14.13B73.74%19.73B92.87%21.18B156.76%26.87B-2.48%14.13B3.59%14.49B-35.50%11.36B
Current changes in cash -289.82%-5.02B90.87%-510M-70.58%3.74B16,441.67%7.84B-24.39%2.01B-295.59%-1.29B-920.12%-5.59B414.60%12.71B-107.06%-48M186.59%2.65B
Effect of exchange rate changes 170.83%119M12.37%-85M-546.43%-125M64.10%-112M5.04%125M41.26%-168M39.75%-97M75.00%28M-75.28%-312M324.53%119M
End cash Position 1.28%19.98B17.44%24.88B-5.18%25.47B54.73%21.86B54.73%21.86B73.74%19.73B92.87%21.18B156.76%26.87B-2.48%14.13B-2.48%14.13B
Free cash flow -12.39%5.71B52.29%4.66B19.05%2.85B3.45%17.78B54.24%5.8B22.32%6.52B-35.18%3.06B-29.00%2.39B-13.02%17.19B-12.83%3.76B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme CAR-T Therapy
CAR-T Therapy
Intraday+0.97%
Infectious Disease
Infectious Disease
Intraday+0.78%